Evidence map›Paper›PMID 23519202›Full record

ArticleMolecules (Basel, Switzerland)2013

Efficient synthesis and anti-fungal activity of oleanolic acid oxime esters.

Hanqing Zhao, Minjie Zhou, Lifeng Duan, Wei Wang, Jianjun Zhang, Daoquan Wang, Xiaomei Liang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Chemical Characteristics and Antimicrobial Activity ofMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Science advances · 2025
    Article
  7. Review
  8. Network pharmacology, molecular docking andFrontiers in medicine · 2025
    Article
  9. Article
  10. Therapeutic potential of oleanolic acid in liver diseases.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Oleanane-Type Triterpene Conjugates with 1Molecules (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Article
  20. Novel SynthesizedInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hanqing ZhaoDepartment of Applied Chemistry, China Agricultural University, Beijing 100193, China.
Minjie Zhou
Lifeng Duan
Wei Wang
Jianjun Zhang
Daoquan Wang
Xiaomei Liang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to develop potential glucosamine-6-phosphate synthase inhibitors and anti-fungal agents, twenty five oleanolic acid oxime esters were synthesized in an efficient way. The structures of the new compounds were confirmed by MS, HRMS, 1H-NMR and 13C-NMR. Preliminary studies based on means of the Elson-Morgan method indicated that many compounds exhibited some inhibitory activity of glucosamine-6-phosphate synthase (GlmS), and the original fungicidal activities results showed that some of the compounds exhibited good fungicidal activities towards Sclerotinia sclerotiorum (Lib.) de Bary, Rhizoctonia solani Kuhn and Botrytis cinerea Pers at the concentration of 50 µg/mL. These compounds would thus merit further study and development as antifungal agents.

Indexed as

Antifungal AgentsAscomycotaBotrytisCandida albicansEnzyme InhibitorsEstersFungal ProteinsFungicides, IndustrialFusariumGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)Microbial Sensitivity TestsOleanolic AcidOximesPhytophthoraPlant DiseasesAntifungal AgentsEnzyme InhibitorsEstersFungal ProteinsFungicides, IndustrialGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)Oleanolic AcidOximes

Identifiers

PMID23519202
PMCPMC6270060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.